Evaluating biomarkers for coronary heart disease prognosis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to recruit patients diagnosed with coronary heart disease who are undergoing coronary angiography and follow them for at least two years. The study will track the incidence of major adverse cardiovascular events (MACE), including mortality and rehospitalization, while collecting blood and fecal samples for analysis. Additionally, it will gather comprehensive data on patients' socio-demographic factors, lifestyle, and medical history to investigate biomarkers and factors contributing to poor prognosis in coronary heart disease through multi-omics analysis.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosed as coronary heart disease or with unexplained chest pain needed to undergo coronary angiography.
* Healthy subjects undergoing routine physical examination in the physical examination department and willing to sign informed consent will be recruited as control subjects.

Exclusion Criteria:

* With malignant tumors, infectious diseases and advanced liver diseases.
* Won't sign an inform consent.

Where it's running

• Shandong First Medical University
  Jinan, Shandong, China Recruiting

Study contacts

• Study coordinator: Rong Huang, Dr.
• Email: huangrong9277@163.com
• Phone: 18854125717

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• NMR-based Risk Test and Digital Health Support for midlife adults in Eloisa

  This study tests whether an NMR metabolomics risk test can guide tailored digital health programs for midlife adults at risk of diabetes, heart disease, stroke, kidney disease, or fatty liver.

  Recruiting University of Eastern Finland · Savonlinna · NCT07820800

• Heart@Home: Safe, at-home care for people with acute heart problems compared with hospital care

  This trial tests whether hospital-level care at home can safely and effectively treat adults with acute heart conditions who would normally be in the hospital.

  Recruiting Tel-Aviv Sourasky Medical Center · Tel Aviv · NCT07913152

• Digital cardiac rehab to help heart attack patients improve function

  A digital health–supported cardiac rehabilitation program is being tested to see if it helps people after a heart attack improve fitness and stay engaged with rehab, compared with standard outpatient rehab.

  Recruiting Cairo University · Minya, Minya Province · NCT07867197

• See if stopping long-term aspirin is as good as continuing it in older adults with stable ischemic heart disease

  In adults 65 and older with stable ischemic heart disease, this trial tests whether stopping daily low-dose aspirin is not worse than continuing it.

  Recruiting at 2 sites Phase 4 Odense University Hospital · Copenhagen and 1 other locations · NCT07795398

• Innate Immune Cells and Early Fibrotic Repair After a Heart Attack

  This study tests whether specific neutrophil and monocyte patterns are linked to early scar formation after a heart attack in STEMI patients.

  Recruiting Shanghai 10th People's Hospital · Shanghai · NCT07764588

• Remote Balance in Everyday Life for young MI patients with distress

  This study tests a remote 6-session program (rBEL) to help adults under 55 who had a heart attack and feel distressed see if the program and study procedures are feasible.

  Recruiting Uppsala University · Uppsala · NCT07706816

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.